HCPCS J7699: Inhalation Solution for DME Administration
HCPCS Level II code J7699 describes a narcotic or controlled inhalation solution supplied for administration through durable medical equipment, representing a medication supply for inhalation therapy; service type is inhalation drug administration via DME and typical site of service is home or outpatient settings where durable medical equipment is used, such as home health or outpatient infusion clinics providing nebulizer-based therapy.
For related coverage guidance, see recent payer policy updates: Bendamustine Products Coverage Criteria, T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and Romidepsin, Brentuximab Vedotin (Adcetris®) Coverage Criteria.
Customize your policy alerts
Sign up for hcpcs J7699 policy alerts
Get alerted when payer policies referencing J7699 are released or updated.
Monitor payer policy activity